8-K current report · filed Nov 9, 2026

MYRIAD GENETICS INC (MYGN) 8-K Current Report: November 9, 2026

Item 5.02MYGN overview

Short answer

MYRIAD GENETICS INC (MYGN) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). One-time retention options target executive continuity during operational-efficiency and financial-performance initiatives.

MYRIAD GENETICS INC 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • One-time retention options target executive continuity during operational-efficiency and financial-performance initiatives
  • CFO Benjamin Wheeler awarded options for 121,379 shares
  • COO Mark Verratti awarded options for 146,933 shares
  • CSO Dale Muzzey awarded options for 92,632 shares
  • Three-year cliff vesting, exercise price set at grant-date closing price, creating a long-term retention commitment

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other MYRIAD GENETICS INC 8-K filings

Get the next MYGN 8-K as it lands

Follow MYGN for push alerts, or ask the research agent what this filing means.